At Sanofi, the new boss is keeping the focus on immunology and vaccines, but is radically revising the method
General Director of the French pharmaceutical group for less than three months, Belén Garijo wants to refocus the strategy of the French pharmaceutical laboratory around research and development.
We haven't written up this one. Le Monde Economie has the full story — the link below goes straight to it.


